These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of three pro-nuclei (3PN) proportion incidence on clinical outcomes of patients with lower retrieved oocytes in the fresh cleavage-stage embryo transfer (ET) cycles. Li M, Zhang S, Shi W, Ren W, Liu Y, Tang Q, Shi J. Gynecol Endocrinol; 2016 Nov; 32(11):891-895. PubMed ID: 27251984 [Abstract] [Full Text] [Related]
11. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. Hohmann FP, Macklon NS, Fauser BC. J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847 [Abstract] [Full Text] [Related]
13. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome]. Zhu RR, Xiao SQ, Zhao JZ, Lin J, Wang PY, Jin CC, Jin WM. Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560 [Abstract] [Full Text] [Related]
14. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients. Michaan N, Ben-David G, Ben-Yosef D, Almog B, Many A, Pauzner D, Lessing JB, Amit A, Azem F. Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845 [Abstract] [Full Text] [Related]
19. Luteal-phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study. Wang N, Wang Y, Chen Q, Dong J, Tian H, Fu Y, Ai A, Lyu Q, Kuang Y. Clin Endocrinol (Oxf); 2016 May; 84(5):720-8. PubMed ID: 26603821 [Abstract] [Full Text] [Related]